Italia markets closed

MRTX211217P00095000

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
0,50000,0000 (0,00%)
Al 01:03PM EST. Mercato aperto.
Schermo intero
Chiusura precedente0,5000
Aperto0,5000
Denaro0,0000
Lettera1,2000
Prezzo d'esercizioN/D
Scadenza2021-12-17
Min-Max giorno0,5000 - 0,5000
Contratto - Min-MaxN/D
VolumeN/D
Open Interest2
  • GlobeNewswire

    (MRTX) Alert: Did You Lose Money on Your Mirati Therapeutics Investment? Contact Johnson Fistel Regarding Investigation

    SAN DIEGO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Mirati Therapeutics, Inc. (NASDAQ: MRTX) for violations of federal securities laws. On November 1, 2021, Mirati, in an SEC filing, disclosed that certain executives would no longer be serving in their positions. In the filing, the Company stated, “On October 28, 2021, it was determined that Daniel R. Faga would cease serving as the Executive Vice President, Chie